Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-02-04

Clinical Trial Update: Evaluating the Synergism of Soluble Dietary Fiber With Fecal Microbiota Transplantation in Slow Transit Constipation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the synergistic effect of soluble dietary fiber with fecal microbiota transplantation for slow-transit constipation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)
  • Soluble dietary fiber (soluble dietary fiber)

Snippet

Sponsor: Jinling Hospital, China | Conditions: Slow Transit Constipation | Phase 2 | Status: UNKNOWN